机构：[1]Department of Cardiology, Zhongnan Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China[2]Institute of Model Animal, Wuhan University, Wuhan, China[3]Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China[4]Department of Cardiology, The Third Xiangya Hospital, Central South University, Changsha 410000, China[5]Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China[6]Departments of Anesthesiology, Physiology, and Medicine, Cardiovascular Research Laboratories, David Geffen School of Medicine,University of California, Los Angeles, Los Angeles, CA, USA[7]Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA 19004, USA[8]Centre for Clinic Pharmacology, The William Harvey Research Institute, Queen Mary University of London, London, UK[9]Department of Cardiology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology,Wuhan, China[10]Department of General Surgery, Huanggang Central Hospital, Huanggang, China[11]Department of Gastroenterology, Wuhan Third Hospital and Tongren Hospital of Wuhan University, Wuhan, China[12]Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan, China华中科技大学同济医学院附属协和医院[13]Department of Neonatology, Renmin Hospital of Wuhan University, Wuhan, China[14]Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine & Key Laboratory of Glucolipid MetabolicDisorder, Ministry of Education of China & Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangdong TCM KeyLaboratory for Metabolic Diseases, Guangzhou 510006, China[15]Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China[16]Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan, China华中科技大学同济医学院附属同济医院
This work was supported by grants from the National Key R&D Program of China (2016YFF0101504 to Z.-G.S. and 2019YFC2004700 to L.Z.), the Special Foundation for Emergency Research on Prevention and Control of COVID-19 of Guangdong Province (2020B1111330003), the National Science Foundation of China (81630011 to Hongliang Li, 81970364 to Z.-G.S., 81970070 to X.-J.Z.,81970011 to P.Z., and 81870171 to J.C.), the Major Research Plan of the National Natural Science Foundation of China (91639304 to Hongliang Li), the Hubei Science and Technology Support Project (2019BFC582, 2018BEC473,and 2017BEC001 to Hongliang Li), and Medical Flight Plan of Wuhan University.
第一作者机构：[1]Department of Cardiology, Zhongnan Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China[2]Institute of Model Animal, Wuhan University, Wuhan, China
共同第一作者：
通讯作者：
通讯机构：[1]Department of Cardiology, Zhongnan Hospital, School of Basic Medical Science, Wuhan University, Wuhan, China[2]Institute of Model Animal, Wuhan University, Wuhan, China[3]Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China[5]Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China
推荐引用方式(GB/T 7714)：
Xu Cheng,Ye-Mao Liu,Haomiao Li,et al.Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes[J].CELL METABOLISM.2020,32(4):537-+.doi:10.1016/j.cmet.2020.08.013.
APA：
Xu Cheng,Ye-Mao Liu,Haomiao Li,Xin Zhang,Fang Lei...&Hongliang Li.(2020).Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes.CELL METABOLISM,32,(4)
MLA：
Xu Cheng,et al."Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes".CELL METABOLISM 32..4(2020):537-+
生物